Jef De Schutter
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 7
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 2
-
- Lung Cancer Treatments and Mutations 2
- Gastric Cancer Management and Outcomes 1
- Co-authors
- Wendy De Roock (7 shared papers)Sabine Tejpar (5 shared papers)Bart Biesmans (5 shared papers)Eric Van Cutsem (5 shared papers)Bart Jacobs (4 shared papers)Jean–Luc Van Laethem (3 shared papers)Hubert Piessevaux (4 shared papers)Marc Peeters (3 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Journal of Clinical Oncology (1 paper)BMC Cancer (1 paper)Molecular Diagnosis & Therapy (1 paper)Digital Access to Libraries (1 paper)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
Jef De Schutter
8 papers receiving 805 citations
Peers
Comparison fields: 5 of 39
- Oncology 625
- Hepatology 101
- Pathology and Forensic Medicine 174
- Cancer Research 139
- Pulmonary and Respiratory Medicine 249
Countries citing papers authored by Jef De Schutter
This map shows the geographic impact of Jef De Schutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jef De Schutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jef De Schutter more than expected).
Fields of papers citing papers by Jef De Schutter
This network shows the impact of papers produced by Jef De Schutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jef De Schutter. The network helps show where Jef De Schutter may publish in the future.
Co-authors
The 25 scholars most cited alongside Jef De Schutter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 283 | |
| 2 | 2009 | 246 | |
| 3 | 2008 | 135 | |
| 4 | 2010 | 60 | |
| 5 | 2014 | 53 | |
| 6 | 2009 | 36 | |
| 7 | High Amphiregulin and Epiregulin expression in K-ras wild type colorectal primaries predicts response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease | 2007 | 10 |
| 8 | PIK3CA mutations do not confer resistance to the EGFR-inhibitor cetuximab in chemorefractory metastatic colorectal cancer | 2009 | 1 |
About Jef De Schutter
Jef De Schutter is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Infectious Diseases and Organic Chemistry, having authored 8 papers that have together received 824 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (2 papers), Lung Cancer Treatments and Mutations (2 papers), Gastric Cancer Management and Outcomes (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Oncology (625 citations), Hepatology (101 citations), Pathology and Forensic Medicine (174 citations), Cancer Research (139 citations) and Pulmonary and Respiratory Medicine (249 citations). Jef De Schutter has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Wendy De Roock, Sabine Tejpar, Bart Biesmans, Eric Van Cutsem, Bart Jacobs, Jean–Luc Van Laethem, Hubert Piessevaux, Marc Peeters, Yves Humblet and Bart Claes. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, BMC Cancer, Molecular Diagnosis & Therapy and Digital Access to Libraries.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.